Stem Cell Treatment for Early-Onset Alzheimer's Disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether tiny particles called exosomes derived from neural stem cells can help slow memory loss and thinking problems in people with Alzheimer's disease that started before age 65. The treatment is given through the nose and aims to reduce harmful proteins in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 50–75 years old, with Alzheimer's symptoms starting before age 65
- Diagnosed with probable Alzheimer's disease based on standard medical criteria
- Brain scan (MRI) showing changes consistent with Alzheimer's but not other conditions, plus a PET scan confirming amyloid buildup
- Able to see and hear well enough to complete study tests, with at least primary school education
- Have a trusted caregiver who can attend visits and help provide information
- Not currently in another clinical trial or having received stem cell therapy in the past 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether infusing donated umbilical cord blood (a source of young immune cells) can help slow Alzheimer's disease. It is for people aged 50–75 with mild to moderate Alzheimer's who have a caregiver and are otherwise generally healthy.
This study tests whether a special type of brain stimulation called temporal interference stimulation can improve memory and thinking skills in people with early-stage Alzheimer's disease. The treatment uses electrical stimulation to target specific brain areas without surgery.
This trial tests a stem cell treatment for people with early-stage Alzheimer's disease. It aims to see if the treatment can help slow memory loss or other symptoms. You must have a specific blood test showing inflammation in the body to qualify.
This trial tests a new drug made from stem cell exosomes (CB-Exo-A600) to see if it can help people with mild to moderate Alzheimer's disease. It aims to slow down symptoms and improve quality of life.
This trial tests a new stem cell treatment (called RB-ADSCs) that is injected into the fluid around your brain. It aims to see if these cells can help slow down memory loss and thinking problems in people with mild to moderate Alzheimer's disease.
This study tests whether human stem cells, combined with your existing Alzheimer's medication (Leqembi or Kisunla), can help slow memory loss and improve daily functioning in people with mild cognitive impairment or early Alzheimer's. You would receive a stem cell infusion as an add-on to your current treatment.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.